When we evaluated the effects of STAP-2 deficiency in CML mouse model, we could not detect any differences in survival period between WT and STAP-2 KO CML mice (Supplementary Fig. S2). Here, STAP2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.